Cargando…

Effects of methylphenidate on neuropsychiatric symptoms in Alzheimer's disease: Evidence from the ADMET 2 study

INTRODUCTION: Methylphenidate has been shown to improve apathy in patients with Alzheimer's disease (AD). The authors evaluated the impact of methylphenidate on neuropsychiatric symptoms (NPS) of AD, excluding apathy, using data from the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2) stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clark, Emily D., Perin, Jamie, Herrmann, Nathan, Brawman‐Mintzer, Olga, Lanctôt, Krista L., Lerner, Alan J., Mintzer, Jacobo, Padala, Prasad R., Rosenberg, Paul B., Sami, Susie, Shade, David M., van Dyck, Christopher H., Porsteinsson, Anton P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394740/ https://www.ncbi.nlm.nih.gov/pubmed/37538343 http://dx.doi.org/10.1002/trc2.12403

Ejemplares similares

The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial
por: Scherer, Roberta W., et al.
Publicado: (2018)

Neurobiologic Rationale for Treatment of Apathy in Alzheimer’s Disease With Methylphenidate
por: van Dyck, Christopher H., et al.
Publicado: (2020)

Global Council on Brain Health: Consensus and Recommendations for Promoting Brain Health Through Music Engagement
por: Mintzer, Jacobo
Publicado: (2020)

POTENTIAL BENEFITS OF THC AND CBD IN THE TREATMENT OF HOSPICE-ELIGIBLE DEMENTED AND AGITATED PATIENTS
por: Mintzer, Jacobo`
Publicado: (2022)

Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition
por: Cummings, Jeffrey, et al.
Publicado: (2015)

Effect of Methylphenidate for Apathy on Visual Attention Scanning Behavior: a Pilot Study
por: Chau, Sarah A., et al.
Publicado: (2018)

A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer’s disease patients with agitation
por: Akil, Ayman, et al.
Publicado: (2015)

Responsiveness of the QUALID to Improved Neuropsychiatric Symptoms in Patients with Alzheimer’s Disease
por: Benhabib, Hadas, et al.
Publicado: (2013)

Combination pharmacotherapy in Alzheimer's disease
por: Mintzer, Jacobo, et al.
Publicado: (2003)

Behavioral and psychological signs and symptoms of dementia: a practicing psychiatrist's viewpoint
por: E. Mintzer, Jacobo, et al.
Publicado: (2000)

Diagnostic criteria for apathy in neurocognitive disorders
por: Miller, David S., et al.
Publicado: (2021)

Changes in QTc Interval in the Citalopram for Agitation in Alzheimer's Disease (CitAD) Randomized Trial
por: Drye, Lea T., et al.
Publicado: (2014)

A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults
por: Richards, Cynthia, et al.
Publicado: (2018)

The pocket idiot's guide to surviving an audit
por: Friedfel, Alan, et al.
Publicado: (2010)

Validity of a novel screen for cognitive impairment and neuropsychiatric symptoms in cardiac rehabilitation
por: Mohammad, Dana, et al.
Publicado: (2019)

Brain amyloid burden, sleep, and 24-hour rest/activity rhythms: screening findings from the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration Studies
por: Spira, Adam P, et al.
Publicado: (2021)

Loneliness and Neuropsychiatric Symptoms in Cognitively Impaired Older Adults during COVID-19 Pandemic
por: Padala, Prasad, et al.
Publicado: (2021)

FP-ADMET: a compendium of fingerprint-based ADMET prediction models
por: Venkatraman, Vishwesh
Publicado: (2021)

Poststroke Neuropsychiatric Symptoms: Relationships with IL-17 and Oxidative Stress
por: Swardfager, W., et al.
Publicado: (2014)

Drug-Induced Hematologic Syndromes
por: Mintzer, David M., et al.
Publicado: (2009)

Lifestyle Choices and Brain Health
por: Mintzer, Jacobo, et al.
Publicado: (2019)

A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
por: Turner, R. Scott, et al.
Publicado: (2015)

ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database
por: Dong, Jie, et al.
Publicado: (2018)

Neonatal NIRS monitoring: recommendations for data capture and review of analytics
por: Vesoulis, Zachary A., et al.
Publicado: (2021)

Isolation of Candidatus Bartonella melophagi from Human Blood
por: Maggi, Ricardo G., et al.
Publicado: (2009)

Evaluation of perampanel as monotherapy for focal seizures: Experience from open-label extension studies
por: Kwan, Patrick, et al.
Publicado: (2017)

Resolving noise–control conflict by gene duplication
por: Chapal, Michal, et al.
Publicado: (2019)

Editorial: Organ Perfusion and Oxygenation in the Sick Infant
por: Kooi, Elisabeth M. W., et al.
Publicado: (2022)

Novel ADMET design tool for chemists
por: Miller, DW, et al.
Publicado: (2011)

Actigraphic Recording of Manic Symptoms Induced by Methylphenidate
por: Lahti, Tuuli, et al.
Publicado: (2009)

Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms
por: Lanctôt, Krista L., et al.
Publicado: (2017)

LGI1 encephalitis with squamous lung-cell carcinoma: Resolution after tumor resection
por: Virupakshaiah, Akash, et al.
Publicado: (2020)

vNN Web Server for ADMET Predictions
por: Schyman, Patric, et al.
Publicado: (2017)

All purulence is local – epidemiology and management of skin and soft tissue infections in three urban emergency departments
por: Merritt, Chris, et al.
Publicado: (2013)

Iron Deficiency and Anemia in Male and Female Adolescent Athletes Who Engage in Ball Games
por: Nicotra, Daniela, et al.
Publicado: (2023)

Sex differences in neuropsychiatric symptoms in Alzheimer’s disease dementia: a meta-analysis
por: Eikelboom, Willem S., et al.
Publicado: (2022)

Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012
por: Herrmann, Nathan, et al.
Publicado: (2013)

Prediction of the Wingate anaerobic mechanical power outputs from a maximal incremental cardiopulmonary exercise stress test using machine-learning approach
por: Leopold, Efrat, et al.
Publicado: (2019)

Methylphenidate-associated myopathy
por: Vargas, Ana Beatriz, et al.
Publicado: (2012)

The cardiovascular safety of methylphenidate
por: Jackson, John W
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4rqakpcm8bv3o2chj8aa0tqjnb